Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Burtness

Showing results (121-130 of 184) with videos related to

Pageof 19
Sort By:
Future Oncology (London, England)|January 30, 2026
JADE: phase 3 study of sequential dostarlimab post chemoradiotherapy in patients with locally advanced unresected HNSCCLillian L Siu, Barbara Burtness, Kevin Harrington, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 14, 2020
PET/CT radiomics signature of human papilloma virus association in oropharyngeal squamous cell carcinomaStefan P Haider, Amit Mahajan, Tal Zeevi, et al.
International Journal of Radiation Oncology, Biology, Physics|March 17, 2010
Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancerKyle E Rusthoven, Steven J Feigenberg, David Raben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2015
A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell CarcinomaThomas J Galloway, Lori J Wirth, Alexander D Colevas, et al.
The Breast Journal|November 18, 2003
Sequential high-dose alkylating therapy and stem cell support for high-risk stage III breast cancerJosette Bou-Khalil, Michal Rose, Amanda Psyrri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2019
Randomized, Phase II Study Prospectively Evaluating Treatment of Metastatic Esophageal, Gastric, or Gastroesophageal Cancer by Gene Expression of <i>ERCC1</i>: SWOG S1201Syma Iqbal, Shannon McDonough, Heinz-Josef Lenz, et al.
Translational Oncology|October 19, 2020
Prediction of post-radiotherapy locoregional progression in HPV-associated oropharyngeal squamous cell carcinoma using machine-learning analysis of baseline PET/CT radiomicsStefan P Haider, Kariem Sharaf, Tal Zeevi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 21, 2024
Impact of <sup>18</sup>F-FDG PET Intensity Normalization on Radiomic Features of Oropharyngeal Squamous Cell Carcinomas and Machine Learning-Generated BiomarkersStefan P Haider, Tal Zeevi, Kariem Sharaf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2022
Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck CancerAlexander Y Deneka, Yasmine Baca, Ilya G Serebriiskii, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2013
Quantification of excision repair cross-complementing group 1 and survival in p16-negative squamous cell head and neck cancersRanee Mehra, Fang Zhu, Dong-Hua Yang, et al.
Pageof 19

Showing results (121-130 of 184) with videos related to

Sort By:
Pageof 19
Future Oncology (London, England)|January 30, 2026
JADE: phase 3 study of sequential dostarlimab post chemoradiotherapy in patients with locally advanced unresected HNSCCLillian L Siu, Barbara Burtness, Kevin Harrington, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 14, 2020
PET/CT radiomics signature of human papilloma virus association in oropharyngeal squamous cell carcinomaStefan P Haider, Amit Mahajan, Tal Zeevi, et al.
International Journal of Radiation Oncology, Biology, Physics|March 17, 2010
Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck cancerKyle E Rusthoven, Steven J Feigenberg, David Raben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2015
A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell CarcinomaThomas J Galloway, Lori J Wirth, Alexander D Colevas, et al.
The Breast Journal|November 18, 2003
Sequential high-dose alkylating therapy and stem cell support for high-risk stage III breast cancerJosette Bou-Khalil, Michal Rose, Amanda Psyrri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2019
Randomized, Phase II Study Prospectively Evaluating Treatment of Metastatic Esophageal, Gastric, or Gastroesophageal Cancer by Gene Expression of <i>ERCC1</i>: SWOG S1201Syma Iqbal, Shannon McDonough, Heinz-Josef Lenz, et al.
Translational Oncology|October 19, 2020
Prediction of post-radiotherapy locoregional progression in HPV-associated oropharyngeal squamous cell carcinoma using machine-learning analysis of baseline PET/CT radiomicsStefan P Haider, Kariem Sharaf, Tal Zeevi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 21, 2024
Impact of <sup>18</sup>F-FDG PET Intensity Normalization on Radiomic Features of Oropharyngeal Squamous Cell Carcinomas and Machine Learning-Generated BiomarkersStefan P Haider, Tal Zeevi, Kariem Sharaf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2022
Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck CancerAlexander Y Deneka, Yasmine Baca, Ilya G Serebriiskii, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2013
Quantification of excision repair cross-complementing group 1 and survival in p16-negative squamous cell head and neck cancersRanee Mehra, Fang Zhu, Dong-Hua Yang, et al.
Pageof 19